To investigate whether reducing TACC3 protein expression in PDAC can inhibit tumor progression, we constructed a mouse subcutaneous tumor model with Panc-1 cells and treated the mice daily with a concentration gradient of MCT, 15 mg/kg KHS101, or 30 mg/kg KHS101. This evidence concerns the gene TACC3 and neoplasm.